Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

RedHill Biopharma (RDHL) Return on Assets: 2012-2024

Historic Return on Assets for RedHill Biopharma (RDHL) over the last 13 years, with Dec 2024 value amounting to -0.40%.

  • RedHill Biopharma's Return on Assets rose 13.00% to -0.85% in Q2 2023 from the same period last year, while for Jun 2023 it was -0.85%, marking a year-over-year increase of 13.00%. This contributed to the annual value of -0.40% for FY2024, which is 67.00% down from last year.
  • Per RedHill Biopharma's latest filing, its Return on Assets stood at -0.40% for FY2024, which was down 253.06% from 0.26% recorded in FY2023.
  • RedHill Biopharma's 5-year Return on Assets high stood at 0.40% for FY2020, and its period low was -0.54% during FY2021.
  • For the 3-year period, RedHill Biopharma's Return on Assets averaged around -0.19%, with its median value being -0.40% (2024).
  • Per our database at Business Quant, RedHill Biopharma's Return on Assets crashed by 94bps in 2021 and then surged by 68bps in 2023.
  • RedHill Biopharma's Return on Assets (Yearly) stood at 0.40% in 2020, then plummeted by 94bps to -0.54% in 2021, then climbed by 12bps to -0.42% in 2022, then soared by 68bps to 0.26% in 2023, then tumbled by 67bps to -0.40% in 2024.